亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢康寶泰精細化工有限公司武昌一部  

醫藥中間體,維生素,植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:付經理
  • 電話:027-87738695
  • 郵件:664219562@qq.com
  • 傳真:027-87738652
  • QQ:664219562
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 5-甲基脲嘧 65-71-4
5-甲基脲嘧 65-71-4
單價 1.00 / 千克對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 1000千克起訂1千克
品牌 康寶泰
型號 65-71-4
規格 25
過期 長期有效
更新 2013-11-28 11:15
 
詳細信息
 5-甲基脲嘧啶
英文名稱: Thymine
英文同義詞: 2,4(1H,3H)-Pyrimidinedione, 5-methyl-;2,4(1H,3H)-Pyrimidinedione,5-methyl-;2,4-Dihydroxy-5-methylpyrimidin;3h)-pyrimidinedione,5-methyl-4(1h;4(1H,3H)-Pyrimidinedione,5-methyl-2;5-Methyl-2,4(1H,3H)-pyrimidinedione;5-Methyl-2,4-dioxypyrimidine;5-Methylpyrimidine-2,4-dione
CAS號: 65-71-4
分子式: C5H6N2O2
分子量: 126.11
EINECS號: 200-616-1
*pounds;Pyrimidines;Biochemistry;Nucleobases and their analogs;Nucleosides, Nucleotides & Related Reagents;Nucleic acids
Mol文件: 65-71-4.mol
熔點  316 °C
儲存條件  Store at RT.
Merck  14,9398
BRN  607626
穩定性 Stable. In*patible with strong oxidizing agents.
CAS 數據庫 65-71-4(CAS DataBase Reference)
NIST化學物質信息 Thymine(65-71-4)
EPA化學物質信息 2,4(1H,3H)-Pyrimidinedione, 5-methyl-(65-71-4)
化學性質  白色結晶粉末,常溫難溶于水。熔點320-330℃。
©2025 武漢康寶泰精細化工有限公司武昌一部 版權所有   技術支持:化工網   訪問量:16944  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |